These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21113230)

  • 21. Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.
    Nachman PH; Hogan SL; Jennette JC; Falk RJ
    J Am Soc Nephrol; 1996 Jan; 7(1):33-9. PubMed ID: 8808107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expanded spectrum of antineutrophil cytoplasmic antibody-negative vasculitis involving vessels from capillaries to medium-sized arteries.
    Qian Q; Thanarajasingam U; Oeckler RA; Sawyer MD; Sethi S; Edwards WD
    Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1634-8. PubMed ID: 22034125
    [No Abstract]   [Full Text] [Related]  

  • 23. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
    Hu W; Liu C; Xie H; Chen H; Liu Z; Li L
    Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recurrence of p-ANCA positive vasculitis with lung hemorrhage in a patient on hemodialysis].
    Merino JL; Galeano C; Martins J; Pascual J; Teruel JL; Ortuño J
    Nefrologia; 2008; 28(4):457-60. PubMed ID: 18662156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-influenza vaccination vasculitides: a possible new entity.
    Zafrir Y; Agmon-Levin N; Shoenfeld Y
    J Clin Rheumatol; 2009 Sep; 15(6):269-70. PubMed ID: 19734729
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment-resistant Churg-Strauss syndrome: progression after five years using rituximab.
    Martínez-Villaescusa M; López-Montes A; López-Rubio E; de la Vara-Iniesta L; Méndez-Molina M; Donate-Ortiz D; Nam-Cha H; Gómez-Roldán C
    Nefrologia; 2013; 33(5):737-9. PubMed ID: 24089169
    [No Abstract]   [Full Text] [Related]  

  • 27. Favourable renal survival in paediatric microscopic polyangiitis: efficacy of a novel treatment algorithm.
    Basu B; Mahapatra TK; Mondal N
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i113-8. PubMed ID: 25758433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing patient survival and renal function outcome in pulmonary-renal syndrome associated with ANCA (+) vasculitis: a single-center experience.
    Stangou M; Asimaki A; Bamichas G; Christidou F; Zoumbaridis N; Natse T; Galanis N; Christaki P; Patakas D; Sombolos K
    J Nephrol; 2005; 18(1):35-44. PubMed ID: 15772921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Off-trial evaluation of the B cell-targeting treatment in the refractory cases of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: long-term follow-up from a single centre.
    Pullerits R; Ljevak M; Vikgren J; Bokarewa M
    Scand J Immunol; 2012 Oct; 76(4):411-20. PubMed ID: 22823472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis and management of small vessel vasculitides].
    Pettersson T; Karjalainen A
    Duodecim; 2010; 126(12):1496-507. PubMed ID: 20617753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Alveolar hemorrhage and glomerulonephritis in two patients with anti-neutrophil cytoplasmic antibodies].
    Takiguchi Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Mar; 35(3):334-40. PubMed ID: 9168652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunotherapy mechanisms in glomerulonephritis].
    Polci R; Feriozzi S
    G Ital Nefrol; 2011; 28(6):612-21. PubMed ID: 22167612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful renal transplantation in a patient with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis: effect of early plasma exchange and mycophenolate mofetil.
    Sun Q; Cheng D; Wen J; Chen J; Gong D; Liu Z; Li L
    Transplant Proc; 2008 Dec; 40(10):3764-6. PubMed ID: 19100484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Renal disease in ANCA-associated vasculitis].
    Vanhille P; Vrigneaud L; Quéméneur T
    Presse Med; 2012 Mar; 41(3 Pt 1):247-53. PubMed ID: 22265953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Negative Small Vessel Vasculitis: A Rare Cause of Pulmonary Renal Syndrome.
    Munshi BD; Sengupta S; Sharan A; Mukhopadhyay S; Ghosh B; Dasgupta A; Bhattacharyya R
    Intern Med; 2015; 54(21):2759-63. PubMed ID: 26521907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Systemic vasculitides: novel nomenclature and novel therapeutic approaches].
    Allali D; Chizzolini C
    Rev Med Suisse; 2014 Apr; 10(426):854-8. PubMed ID: 24834643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of acute c-ANCA-positive vasculitis with mycophenolate mofetil.
    Waiser J; Budde K; Braasch E; Neumayer HH
    Am J Kidney Dis; 1999 Sep; 34(3):e9. PubMed ID: 10471756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ANCA-associated necrotizing/granulomatous glomerulonephritis in an elderly patient; importance of the renal biopsy.
    Isaac J; Clayton F; Rohr R; Herrera GA
    Rev Invest Clin; 2001; 53(1):88-90. PubMed ID: 11332056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-cell depleting agents for ANCA vasculitides: a new therapeutic approach.
    Gómez-Puerta JA; Quintana LF; Stone JH; Ramos-Casals M; Bosch X
    Autoimmun Rev; 2012 Jul; 11(9):646-52. PubMed ID: 22146313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.
    Andreiana I; Stancu S; Avram A; Taran L; Mircescu G
    BMC Nephrol; 2015 Jun; 16():90. PubMed ID: 26123651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.